ZYDUSWELL — Zydus Wellness Share News
0.000.00%
Last trade - 00:00Consumer DefensivesBalancedMid CapFalling Star
- IN₹102.94bn
- IN₹104.63bn
- IN₹20.09bn
- 68
- 11
- 32
- 25
BRIEF-India's Zydus Wellness Reports Sept-Quarter Consol Net Profit Versus Loss Year Ago
NewsBRIEF-India's Zydus Wellness June Qtr Consol Net Profit Rises
NewsBRIEF-Zydus Wellness March Qtr Consol Net Profit Rises
NewsBRIEF-Zydus Wellness Dec Quarter Consol Net Profit Falls
NewsMEDIA-Zydus Cadila to apply for Phase-3 trials in Dec, hopes to launch vaccine by March- Economic Times
NewsBRIEF-India's Zydus Wellness Sept-Quarter Consol Net Loss Widens
NewsMEDIA-India's Zydus in talks with Russian Direct Investment Fund for Sputnik V vaccine - Financial Express
NewsBRIEF-Zydus Wellness To Raise Up To 7.5 Bln Rupees Via Share Issue
NewsBRIEF-Zydus Wellness Says To Consider Proposals For Raising Funds
NewsBRIEF-Zydus Wellness Says 'Cautiously Optimistic' About Next Two Qtrs
NewsBRIEF-Zydus Wellness March Quarter Consol Profit Rises
NewsBRIEF-Zydus Wellness Approves Re-Appointment Of Tarun Arora As CEO For 5 Yrs W.E.F. May 7
NewsBRIEF-Zydus Wellness Declares Interim Dividend Of 5 Rupees Per Share
NewsBRIEF-Zydus And Xoma Announce Il-2-Based Immuno-Oncology Therapy Licensing Agreement
NewsBRIEF-Zydus Cadila Says Drug Controller General Of India Approved New Drug Application For Saroglitazar For Treatment Of Non-Cirrhotic Nash In India
NewsBRIEF-India's Zydus Wellness Dec Quarter Consol Profit Falls
NewsBRIEF-India's Zydus Wellness Posts Sept Qtr Net Loss
NewsBRIEF-India's Zydus Wellness June-Qtr Consol Net PAT Rises
NewsBRIEF-India's Zydus Wellness March Quarter Consol Profit Rises
News